Review

The Role of Artificial Intelligence in Combating Antimicrobial Resistance

Volume: 55 Number: 3 January 14, 2026

The Role of Artificial Intelligence in Combating Antimicrobial Resistance

Abstract

The widespread use of antimicrobials has undeniably played a pivotal role in saving millions of lives; however, their misuse and inappropriate prophylactic application have significantly contributed to the emergence of antimicrobial resistance (AMR), a critical issue that increasingly threatens global health. The World Health Organisation (WHO) estimates that by 2050, AMR could result in as many as 10 million deaths annually. In response to this urgent crisis, many countries have initiated measures to combat AMR. A significant challenge in addressing AMR lies in the difficulties associated with discovering new antimicrobial agents, coupled with the rapid development of resistance to existing treatments. Despite the heightened awareness surrounding the AMR crisis, there remains a pressing need for innovative solutions, including the development of new antimicrobial drugs, novel antibiotic combinations, and improved strategies such as enhanced monitoring systems to effectively manage this growing threat. Artificial Intelligence (AI) has emerged as a promising approach in the fight against AMR. In the field of infectious diseases, AI has the potential to revolutionise the identification and management of resistance patterns. While AI technologies have begun to serve as valuable tools for predicting antimicrobial resistance (AMR) trends, there is substantial potential for further advancements. This review explores how AI technology can be leveraged to combat AMR and enhance the efficacy of the healthcare industry in addressing this global challenge.

Keywords

References

  1. Achanta, A. S., Kowalski, J. G., & Rhodes, C. T. (1995). Artificial neural networks: implications for pharmaceutical sciences. Drug Development and Industrial Pharmacy, 21(1), 119-155. https://doi.org/10.3109/03639049509048099 google scholar
  2. Ang, T. L., Choolani, M., & Poh, K. K. (2023). The rise of artificial intelligence: addressing the impact of large language models such as ChatGPT on scientific publications. Singapore medical journal, 64(4), 219-221. 10.4103/singaporemedj. SMJ-2023-055 google scholar
  3. Badura, A., Krysiński, J., Nowaczyk, A., & Buciński, A. (2021). Application of artificial neural networks to prediction of new substances with antimicrobial activity against Escherichia coli. Journal of Applied Microbiology, 130(1), 40-49. https://doi.org/10.1111/jam.14763 google scholar
  4. Baum, E. B. (1988). On the capabilities of multilayer perceptrons. Journal of complexity, 4(3), 193-215. https://doi.org/10.1016/0885-064X(88)90020-9 google scholar
  5. Begley, R. J., Riege, M., Rosenblum, J., & Tseng, D. (2000). Adding intelligence to medical devices. Medical Device and Diagnostic Industry, 22(3), 150-175. https://www.researchgate. net/publication/292008212_Adding_intelligence_to_medical_devices google scholar
  6. Bilge, U. (2007). Tıpta yapay zeka ve uzman sistemler [Artificial intelligence and expert systems in medicine]. 4th Turkish Informatics Association Congress, 113- 118. google scholar
  7. Bozkurt-Guzel, C., Alkan, B., & Oyardi, O. (2019). Antimikrobiyal Tedaviye Alternatif Stratejiler [ Alternative Strategies for Antimicrobial Therapy]. Turkish Pharmacopoeia Journal, 4(2), 129-139. https://www.scribd.com/document/495130171/TurkFarmakopeDergisi-4-2-c4a5942c-ffc9-423c-b844-f3782ac30925 google scholar
  8. Burckhardt, I., & Zimmermann, S. (2018). Susceptibility testing of bacteria using MALDI-TOF mass spectrometry. Frontiers in Microbiology, 9, 1744. https://doi.org/10.3389/fmicb. 2018.01744 google scholar

Details

Primary Language

English

Subjects

Pharmaceutical Microbiology

Journal Section

Review

Publication Date

January 14, 2026

Submission Date

January 14, 2025

Acceptance Date

June 11, 2025

Published in Issue

Year 2025 Volume: 55 Number: 3

APA
Alkan, B., & Bozkurt Güzel, Ç. (2026). The Role of Artificial Intelligence in Combating Antimicrobial Resistance. İstanbul Journal of Pharmacy, 55(3), 540-546. https://doi.org/10.26650/IstanbulJPharm.2025.1619551
AMA
1.Alkan B, Bozkurt Güzel Ç. The Role of Artificial Intelligence in Combating Antimicrobial Resistance. iujp. 2026;55(3):540-546. doi:10.26650/IstanbulJPharm.2025.1619551
Chicago
Alkan, Büşra, and Çağla Bozkurt Güzel. 2026. “The Role of Artificial Intelligence in Combating Antimicrobial Resistance”. İstanbul Journal of Pharmacy 55 (3): 540-46. https://doi.org/10.26650/IstanbulJPharm.2025.1619551.
EndNote
Alkan B, Bozkurt Güzel Ç (January 1, 2026) The Role of Artificial Intelligence in Combating Antimicrobial Resistance. İstanbul Journal of Pharmacy 55 3 540–546.
IEEE
[1]B. Alkan and Ç. Bozkurt Güzel, “The Role of Artificial Intelligence in Combating Antimicrobial Resistance”, iujp, vol. 55, no. 3, pp. 540–546, Jan. 2026, doi: 10.26650/IstanbulJPharm.2025.1619551.
ISNAD
Alkan, Büşra - Bozkurt Güzel, Çağla. “The Role of Artificial Intelligence in Combating Antimicrobial Resistance”. İstanbul Journal of Pharmacy 55/3 (January 1, 2026): 540-546. https://doi.org/10.26650/IstanbulJPharm.2025.1619551.
JAMA
1.Alkan B, Bozkurt Güzel Ç. The Role of Artificial Intelligence in Combating Antimicrobial Resistance. iujp. 2026;55:540–546.
MLA
Alkan, Büşra, and Çağla Bozkurt Güzel. “The Role of Artificial Intelligence in Combating Antimicrobial Resistance”. İstanbul Journal of Pharmacy, vol. 55, no. 3, Jan. 2026, pp. 540-6, doi:10.26650/IstanbulJPharm.2025.1619551.
Vancouver
1.Büşra Alkan, Çağla Bozkurt Güzel. The Role of Artificial Intelligence in Combating Antimicrobial Resistance. iujp. 2026 Jan. 1;55(3):540-6. doi:10.26650/IstanbulJPharm.2025.1619551